background
identif
broad
neutral
epitop
envelop
spike
paramount
vaccin
develop
broad
neutral
epitop
identifi
far
present
surfac
nativ
envelop
spike
whose
recognit
antibodi
depend
conform
chang
envelop
spike
howev
envelop
spike
also
contain
transientlyexpos
neutral
epitop
difficult
identifi
result
studi
construct
singl
chain
fv
scfv
deriv
seven
human
monoclon
antibodi
genet
link
without
glycosylphosphatidylinositol
gpi
attach
signal
show
gpi
attach
signal
scfv
target
lipid
raft
plasma
membran
addit
demonstr
four
gpianchor
scfv
secret
counterpart
neutral
variou
degre
breadth
potenc
among
gpianchor
scfv
exhibit
extrem
potent
broad
neutral
activ
multipl
clade
strain
test
moreov
show
gpianchor
scfv
also
exhibit
potent
neutral
activ
secretori
counterpart
final
demonstr
express
gpianchor
scfv
lipid
raft
plasma
membran
human
cell
confer
longterm
resist
infect
envelopemedi
cellcel
fusion
infect
captur
transfer
human
dc
conclus
thu
gpianchor
scfv
could
use
gener
effect
way
identifi
antibodi
react
transientlyexpos
neutral
epitop
envelop
protein
envelop
virus
gpianchor
scfv
breadth
potenc
great
potenti
develop
antivir
agent
prevent
therapi
human
immunodefici
viru
type
envelop
spike
trimer
complex
consist
three
noncoval
link
heterodim
exterior
glycoprotein
mediat
cell
attach
receptor
coreceptor
bind
transmembran
glycoprotein
mediat
viral
cell
membran
fusion
critic
viral
core
enter
target
cell
deriv
cleavag
common
precursor
envelop
spike
also
elicit
antibodi
respons
neutral
antibodi
block
viral
entri
recogn
epitop
envelop
spike
critic
attach
receptor
coreceptor
interact
fusion
appear
import
compon
protect
immun
respons
howev
antibodi
neutral
broad
rang
primari
isol
extrem
difficult
gener
despit
two
decad
effort
broadli
neutral
antibodi
identifi
screen
antibodi
librari
memori
b
cell
infect
individu
unfortun
mani
effort
elicit
antibodi
respons
activ
immun
success
interestingli
neutral
epitop
recogn
aforement
broadli
neutral
antibodi
present
surfac
nativ
spike
recognit
antibodi
depend
conform
chang
envelop
protein
upon
interact
receptor
lipid
raftassoci
protein
target
cell
surfac
nativ
envelop
spike
goe
extens
conform
chang
allow
addit
bind
coreceptor
tcell
tropic
strain
macrophagetrop
isol
coreceptor
bind
result
conform
chang
lead
insert
fusion
peptid
target
cell
membran
drive
subsequ
fusion
event
conform
chang
epitop
hidden
total
expos
surfac
nativ
spike
transient
expos
becom
access
antibodi
specif
transientlyexpos
epitop
like
epitop
also
neutral
epitop
base
assumpt
sever
group
report
use
complex
immunogen
elicit
antibodi
react
transientlyexpos
neutral
epitop
select
antigen
screen
human
phage
display
antibodi
librari
hypothes
complex
envelop
may
stabil
transientlyexpos
epitop
antibodi
present
librari
recogn
stabil
epitop
select
one
notabl
exampl
identif
antibodi
phage
display
fab
antibodi
librari
complex
previous
unexpectedli
found
genet
link
scfv
human
antibodi
transmembran
domain
subunit
one
type
interferon
receptor
cellsurfac
express
scfv
secretori
form
markedli
inhibit
entri
envelopemedi
cellcel
fusion
antibodi
recogn
cluster
ii
determin
amino
acid
residu
resid
within
second
heptad
repeat
mediat
fusion
trigger
interact
second
first
heptad
repeat
convert
prehairpin
trimer
fusogen
threehairpin
bundl
similarli
report
express
peptid
deriv
domain
surfac
cell
exhibit
greater
inhibitori
effect
inhibit
achiev
captur
fusion
intermedi
cellsurfac
express
peptid
prior
viral
cell
membran
fusion
thu
clear
cellsurfac
express
scfv
peptid
recogn
deriv
domain
captur
transientlyexpos
epitop
entri
fusion
intermedi
howev
clear
whether
transientlyexpos
epitop
envelop
spike
resid
domain
also
captur
cellsurfac
express
scfv
natur
cell
surfac
protein
variou
function
anchor
plasma
membran
coval
attach
glycosylphosphatidylinositol
gpi
anchor
mani
gpianchor
protein
target
lipid
raft
plasma
membran
special
dynam
microdomain
rich
cholesterol
sphingolipid
glycerophospholipid
lipid
raft
known
gateway
bud
furthermor
involv
lipid
raft
entri
cell
macrophag
also
propos
therefor
hypothes
one
express
antibodi
react
transientlyexpos
neutral
epitop
gpi
anchor
form
gpi
anchor
target
antibodi
lipid
raft
plasma
membran
cell
antibodi
neutral
infect
correct
predict
nativ
spike
interact
receptor
trigger
seri
conform
chang
transientlyexpos
neutral
epitop
captur
gpianchor
antibodi
resid
lipid
raft
plasma
membran
test
hypothesi
studi
construct
scfv
deriv
seven
differ
human
monoclon
antibodi
recogn
influenza
hemagglutinin
use
neg
control
zhou
et
al
data
shown
high
affin
antibodi
recogn
cluster
iii
determin
interact
epitop
well
character
antibodi
recogn
cluster
ii
determin
amino
acid
residu
resid
within
second
heptad
repeat
antibodi
recogn
distinct
partial
overlap
induc
epitop
locat
close
coreceptorbind
site
antibodi
recogn
linear
epitop
resid
membran
proxim
region
neutral
antibodi
show
genet
link
scfv
gpi
attach
signal
deriv
decay
acceler
factor
daf
scfv
target
lipid
raft
plasma
membran
addit
demonstr
four
gpianchor
scfv
secretori
counterpart
neutral
variou
degre
breadth
potenc
among
gpianchor
scfv
exhibit
extrem
potent
broad
neutral
activ
multipl
clade
strain
test
moreov
show
gpianchor
scfv
also
exhibit
potent
neutral
activ
secretori
counterpart
final
demonstr
express
gpianchor
scfv
lipid
raft
plasma
membran
human
cell
confer
longterm
resist
infect
envelopemedi
cellcel
fusion
infect
captur
transfer
human
dc
thu
conclud
gpianchor
scfv
effect
way
captur
transientlyexpos
neutral
epitop
envelop
spike
express
scfv
lipid
raft
plasma
membran
gpi
anchor
gener
gpianchor
secretori
scfv
sequenc
encod
scfv
deriv
seven
differ
human
antibodi
genet
link
sequenc
encod
histag
hing
region
without
sequenc
encod
gpi
attach
signal
daf
fusion
gene
hingehistag
daf
hingehistag
insert
third
gener
lentivir
vector
prrl
figur
recombin
virus
gener
describ
use
transduc
tzmbl
cell
human
cell
cemss
see
express
transgen
local
transgen
product
transduc
cell
care
studi
figur
show
express
scfvshingehistag
daf
scfvshingehistag
cell
lysat
cultur
supernat
transduc
tzmbl
cell
western
blot
use
antihistag
antitubulin
antibodi
expect
without
gpi
attach
signal
scfv
detect
cultur
supernat
cell
lysat
major
supernat
right
panel
contrast
scfv
gpi
attach
signal
detect
cell
lysat
cultur
supernat
left
panel
data
indic
inclus
gpi
attach
signal
prevent
secret
scfv
determin
scfvshingehistagdaf
express
cell
surfac
gpi
anchor
scfvhingehistagdaftransduc
tzmbl
cell
treat
without
phosphatidylinositolspecif
phospholipas
c
piplc
stain
antihistag
antibodi
follow
fac
analysi
control
cell
transduc
previous
report
mscfv
cellsurfac
express
scfv
convent
transmembran
domain
went
piplc
treatment
stain
process
figur
show
scfvhingehistagdaf
express
highli
cell
surfac
higher
mscfv
express
substanti
reduc
piplc
treatment
contrast
reduct
cell
surfac
express
scfv
observ
mscfvtransduc
cell
indic
express
scfvhingehistagdaf
cell
surfac
inde
gpi
anchor
addit
cell
surfac
express
gpianchor
scfv
along
gpianchor
scfv
also
analyz
immun
stain
fac
analysi
addit
file
show
cell
surfac
express
gpianchor
scfv
similar
gpianchor
scfv
thu
sake
simplic
remain
text
refer
scfvhingehistagdaf
gpiscfv
scfvhing
histag
secretori
scfv
determin
gpiscfv
locat
lipid
raft
plasma
membran
mockand
gpiscfv
transduc
tzmbl
cell
seed
well
cover
slip
chamber
cultur
overnight
cell
fix
formaldehyd
costain
mous
antihistag
antibodi
follow
alexa
goat
antimous
igg
antibodi
alexa
cholera
toxin
subunit
b
ctxb
dapi
ctxb
interact
lipid
raft
marker
cell
surfac
figur
show
gpiscfv
coloc
cell
surfac
impli
locat
lipid
raft
plasma
membran
gpiscfv
exhibit
remark
degre
breadth
potenc
next
compar
express
secretori
gpiscfvtransduc
tzmbl
cell
found
signific
differ
express
compar
mocktransduc
tzmbl
cell
suggest
express
transgen
alter
express
receptor
coreceptor
transduc
cell
addit
file
neither
find
express
transgen
alter
cell
growth
zhou
et
al
data
shown
test
neutral
activ
secretori
versu
gpiscfv
eleven
multiclad
pseudotyp
panel
retrovir
envelop
pseudotyp
use
infect
transduc
tzmbl
cell
singleround
infect
experi
retrovir
envelop
recogn
either
receptor
cell
entri
use
neg
control
eleven
pseudotyp
consist
envelop
deriv
clade
clade
b
jfrl
ada
consensu
b
clade
b
clade
c
clade
e
figur
show
mean
standard
deviat
rel
luciferas
activ
rla
mock
secretori
gpiscfvtransduc
cell
infect
pseudotyp
compar
mocktransduc
cell
cell
transduc
secretori
gpianchor
scfv
show
signific
neutral
activ
pseudotyp
control
figur
compar
mocktransduc
cell
cell
transduc
secretori
scfv
show
signific
neutral
activ
pseudotyp
test
cell
transduc
secretori
scfv
show
low
degre
neutral
activ
pseudotyp
ada
consensu
b
contrast
cell
transduc
secretori
scfv
exhibit
neutral
activ
pseudotyp
test
figur
compar
mocktransduc
cell
cell
figur
express
secretori
gpianchor
scfv
transduc
tzmbl
cell
schemat
diagram
lentivir
vector
prrlscfvhingehistagdaf
prrlscfvhingehistag
singl
chain
fv
scfv
deriv
seven
human
monoclon
antibodi
hing
human
hing
region
histag
histidin
residu
tag
daf
ctermin
amino
acid
residu
decay
acceler
factor
b
western
blot
analysi
express
scfv
tzmbl
cell
transduc
lentivir
vector
prrlscfvhingehistagdaf
prrlscfvhingehistag
gpiscfv
gpianchor
scfv
secscfv
secretori
scfv
antihi
antihistag
antibodi
c
fac
analysi
cell
surfac
express
scfvhingehistagdaf
mock
scfv
hingehistagdafor
mscfv
transduc
tzmbl
cell
without
piplc
treatment
wen
et
al
retrovirolog
http
transduc
gpiscfv
show
variou
degre
potenc
breadth
pseudotyp
figur
like
cell
transduc
gpiscfv
control
cell
transduc
gpiscfv
show
neutral
breadth
potenc
pseudotyp
test
cell
transduc
gpiscfv
neutral
pseudotyp
jrfl
consensu
b
low
degre
potenc
cell
transduc
gpiscfv
neutral
pseudovirus
express
envelop
deriv
clade
b
b
variou
degre
potenc
clade
c
e
cell
transduc
gpiscfv
neutral
pseudotyp
increas
potenc
neutral
activ
compar
cell
transduc
secretori
scfv
cell
transduc
gpiscfv
neutral
pseudotyp
great
degre
potenc
pseudotyp
express
envelop
deriv
clade
b
b
e
less
potent
envelop
deriv
clade
c
strikingli
cell
transduc
gpiscfv
neutral
pseudotyp
remark
degre
potenc
next
test
neutral
activ
secretori
versu
gpiscfv
replic
compet
strain
includ
two
clinic
isol
quasispeci
figur
show
mean
standard
deviat
rla
mock
secretori
gpiscfvtransduc
cell
infect
strain
compar
mocktransduc
cell
cell
transduc
secretori
scfv
show
signific
neutral
activ
strain
test
figur
contrast
cell
transduc
gpiscfv
show
variou
degre
breadth
potenc
figur
like
cell
transduc
gpiscfv
control
cell
transduc
gpiscfv
neutral
strain
test
cell
transduc
gpiscfv
previous
show
scfv
neutral
better
fab
whole
igg
bind
neutral
capabl
scfv
greatli
enhanc
ad
solubl
extracellular
domain
human
therefor
produc
purifi
solubl
use
drosophila
express
system
see
addit
file
test
effect
dose
infect
found
higher
concentrationdepend
inhibit
infect
observ
signific
inhibit
observ
zhou
et
al
data
shown
thu
chose
concentr
subsequ
experi
describ
figur
show
mean
standard
deviat
rla
mock
secretori
gpiscfvtransduc
tzmbl
cell
infect
without
preincub
without
preincub
tcid
two
strain
greatli
enhanc
inhibit
cell
transduc
secretori
scfv
complet
inhibit
observ
gpiscfv
transduc
cell
infect
tcid
two
strain
regardless
whether
virus
preincub
figur
thu
result
clearli
show
enhanc
inhibit
secretori
scfv
gpiscfv
exhibit
greatest
potenc
inhibit
total
independ
addit
gpiscfv
confer
longterm
resist
human
cell
next
evalu
gpiscfv
would
confer
longterm
resist
human
cell
human
cell
line
cemss
first
transfect
retrovir
vector
express
human
stabl
cell
establish
transduc
secretori
gpiscfv
express
secretori
gpiscfv
well
transduc
cell
test
western
blot
immun
stain
follow
fac
analysi
describ
see
addit
file
transduc
cell
infect
strain
multipl
infect
describ
cultur
complet
dmem
medium
day
except
cell
transduc
secretori
scfv
infect
cultur
cell
termin
day
post
infect
shown
figur
replic
complet
inhibit
cell
transduc
gpiscfv
throughout
experi
contrast
robust
replic
observ
cell
transduc
secretori
scfv
gpiscfv
control
cell
transduc
secretori
scfv
infect
replic
robust
secretori
scfv
gpiscfv
control
contrast
cell
transduc
secretori
scfv
infect
robust
replic
observ
first
day
slowli
drop
undetect
level
day
thereaft
data
demonstr
gpiscfv
complet
inhibit
infect
maintain
longterm
resist
contrari
secretori
scfv
inhibit
infect
replic
fast
replic
like
partial
inhibit
replic
rel
slow
replic
like
evalu
effect
gpiscfv
envelopemedi
cellcel
fusion
gpiscfv
transduc
cell
cocultur
cell
previous
describ
latter
contain
envelop
gene
tetoff
promot
presenc
tetracyclin
bind
tetracyclin
tet
transactiv
tta
caus
conform
chang
tta
block
tta
bind
tetoff
promot
prevent
envelop
protein
express
absenc
tetracyclin
tta
bind
transactiv
tetoff
promot
result
envelop
protein
express
figur
cocultur
gpiscfv
transduc
cell
tetracyclinetr
cell
result
cellcel
fusion
figur
contrast
cocultur
gpiscfv
transduc
cell
tetracyclineuntr
cell
result
massiv
cellcel
fusion
figur
fusion
begin
hour
peak
hour
importantli
cellcel
fusion
observ
hour
cocultur
gpiscfv
transduc
cell
tetracyclineuntr
cell
figur
experi
repeat
twice
similar
result
thu
data
demonstr
gpiscfv
complet
inhibit
envelopemedi
cellcel
fusion
test
effect
gpiscfv
infect
captur
transfer
human
dc
monocytederiv
human
dc
incub
cell
wash
extens
remov
free
virus
infect
dc
cocultur
gpiscfv
transduc
cemss
cell
day
replic
measur
assay
describ
shown
figur
cocultur
gpiscfv
transduc
cemss
cell
infect
monocytederiv
human
dc
result
high
express
indic
robust
replic
contrast
cocultur
gpiscfv
transduc
cemss
cell
infect
monocytederiv
human
dc
result
low
level
first
day
drop
thereaft
indic
inhibit
viral
replic
low
level
replic
detect
cocultur
gpiscfv
transduc
cemss
cell
infect
monocytederiv
human
dc
like
reflect
slow
covert
replic
monocytederiv
human
dc
previous
report
thu
data
clearli
demonstr
gpiscfv
neutral
captur
transfer
human
dc
final
transduc
parent
cell
gpiscfv
secretori
scfv
vsvg
pseudotyp
vector
express
enhanc
green
fluoresc
protein
egfp
describ
vsv
g
envelop
interact
lipid
moieti
lipid
bilay
plasmic
membran
vector
pass
requir
interact
envelop
receptor
coreceptor
enter
cell
found
three
dose
test
transduc
parent
cell
gpiscfv
secretori
scfv
studi
demonstr
genet
link
scfv
gpiattach
signal
scfv
express
lipid
raft
plasma
membran
gpi
anchor
figur
gpiscfv
secretori
scfv
antibodi
recogn
transientlyexpos
epitop
envelop
spike
neutral
variou
degre
breadth
potenc
among
gpiscfv
exhibit
extrem
potent
broad
neutral
activ
multipl
clade
figur
moreov
show
gpianchor
scfv
also
exhibit
potent
neutral
activ
secretori
counterpart
figur
importantli
express
gpiscfv
surfac
human
cell
confer
longterm
resist
infect
envelopemedi
cellcel
fusion
infect
captur
transfer
human
dc
figur
thu
target
scfv
antibodi
molecul
lipid
raft
plasma
membran
suscept
cell
gpi
anchor
effect
way
captur
transient
expos
neutral
epitop
envelop
spike
gpiscfv
remark
breadth
potenc
potenti
develop
antivir
agent
prevent
therapi
exampl
similar
recent
report
digiusto
et
al
gpiscfv
could
deliv
hematopoiet
progenitor
cell
patient
ex
vivo
lentivir
vector
transduc
cell
could
transfus
patient
howev
order
achiev
clinic
efficaci
gene
therapi
approach
mani
hurdl
low
degre
transduct
effici
engraft
difficulti
mainten
self
renew
well
hematopoiet
linag
cell
differenti
transduc
hematopoiet
progenitor
cell
unsustain
transgen
express
potenti
insert
mutagenesi
overcom
interestingli
although
level
express
cell
surfac
similar
figur
gpiscfv
test
studi
display
wide
spectrum
breadth
potenc
pseudotyp
wild
type
strain
test
figur
one
end
spectrum
gpiscfv
show
signific
neutral
activ
virus
end
spectrum
gpiscfv
neutral
virus
remark
degre
potenc
two
extrem
gpiscfv
show
progress
increas
breadth
potenc
furthermor
although
recogn
epitop
gpiscfv
gpiscfv
show
differ
potenc
strain
clade
c
similar
potenc
strain
clade
b
b
e
thu
result
strongli
suggest
breadth
potenc
given
gpiscfv
depend
local
concentr
depend
fine
specif
transientlyexpos
neutral
epitop
target
studi
also
show
potent
inhibit
gpiscfv
depend
addit
see
figur
believ
like
someth
epitop
epitop
resid
within
conserv
region
amino
acid
residu
core
particularli
vicin
amino
acid
residu
posit
proxim
coreceptor
bind
site
accord
crystal
structur
core
without
well
crystal
structur
complex
contain
core
receptor
fab
amino
acid
residu
resid
core
form
antiparallel
sheet
without
ad
away
cover
loop
partial
cover
loop
secretori
scfv
neutral
activ
contrast
ad
induc
conform
conform
total
expos
also
becom
close
result
ad
greatli
enhanc
neutral
activ
secretori
scfv
figur
howev
plausibl
even
presenc
conform
spike
transient
secretori
scfv
may
abl
catch
epitop
spike
virion
result
neutral
activ
optim
gpiscfv
hand
due
lipid
raft
locat
local
concentr
may
much
better
access
transientlyexpos
neutral
epitop
upon
interact
nativ
envelop
spike
raftassoci
protein
resid
lipid
raft
plasma
membran
target
cell
locat
gpiscfv
result
gpiscfv
may
quickli
effici
captur
neutral
epitop
complet
block
envelop
spike
prefus
intermedi
step
howev
underli
mechan
great
potenc
gpiscfv
remain
elucid
least
two
implic
find
studi
first
given
promis
result
obtain
studi
plausibl
develop
gpiscfv
standard
approach
identifi
antibodi
recogn
transientlyexpos
epitop
envelop
spike
conceiv
mani
antibodi
poor
neutral
activ
nativ
envelop
spike
gpiscfv
antibodi
made
test
panel
differ
variant
subtyp
gpiscfv
exhibit
good
neutral
activ
one
use
gpiscfv
combin
epitop
map
method
alaninescan
mutant
identifi
transientlyexpos
neutral
epitop
envelop
spike
second
also
plausibl
gpiscfv
use
identifi
antibodi
recogn
transientlyexpos
epitop
identifi
transientlyexpos
neutral
epitop
virus
particularli
envelop
virus
whose
entri
target
cell
depend
lipid
raft
interact
envelop
glycoprotein
receptor
result
conform
chang
shown
glycoprotein
influenza
viru
murin
leukemia
viru
measl
viru
ebola
viru
associ
lipid
raft
plasma
membran
entri
mani
envelop
virus
vaccinia
viru
sever
acut
respiratori
syndromecoronaviru
duck
hepat
b
viru
murin
leukemia
viru
herp
simplex
viru
requir
cholesterol
target
cell
membran
therefor
develop
gpiscfv
deriv
antibodi
recogn
transientlyexpos
epitop
glycoprotein
virus
may
also
effect
way
inhibit
cell
entri
virus
gpi
anchor
scfv
recogn
differ
transientlyexpos
epitop
envelop
spike
exhibit
variou
degre
breadth
potenc
among
gpiscfv
recogn
epitop
near
bind
site
coreceptor
bind
site
exhibit
greatest
potenc
breadth
multiclad
strain
data
therefor
demonstr
gpiscfv
may
develop
use
tool
identifi
antibodi
recogn
transientlyexpos
epitop
glycoprotein
spike
hiv
envelop
virus
gpiscfv
deriv
antibodi
could
effect
way
inhibit
cell
entri
hiv
envelop
virus
provir
plasmid
obtain
nih
aid
research
refer
reagent
program
arrrp
germantown
md
infecti
viru
stock
tropic
subtyp
b
tropic
subtyp
b
tropic
subtyp
c
produc
transfect
cell
use
calcium
phosphat
precipit
reagent
method
roch
diagnost
mannheim
germani
viru
stock
propag
infect
phytohemagglutinin
pha
stimul
human
peripher
blood
mononuclear
cell
pbmc
infecti
clone
describ
primari
isol
jsjcd
gener
infect
phastimul
human
pbmc
plasma
two
subject
cohort
individu
recruit
studi
fit
inform
consent
obtain
particip
accord
institut
review
board
huashan
hospit
shanghai
china
viru
stock
jsjcd
store
aliquot
degre
freezer
titer
stock
determin
endpoint
titrat
tzmbl
cell
see
packag
cell
line
purchas
invitrogen
life
technolog
san
diego
ca
maintain
complet
dmem
medium
ie
high
glucos
dmem
supplement
fb
mm
lglutamin
mm
sodium
pyruv
penicillin
uml
streptomycin
plu
invitrogen
life
technolog
human
cell
line
cemss
obtain
dr
jon
allan
depart
virolog
immunolog
southwest
foundat
biomed
research
san
antonio
tx
tzmbl
cell
obtain
nih
arrrp
contribut
j
kapp
x
wu
h
yu
respect
cemss
cell
tzmbl
cell
maintain
complet
dmem
cell
maintain
complet
dmem
plu
mgml
drosophila
schneider
cell
purchas
invitrogen
life
technolog
maintain
cm
flask
corn
cell
densiti
cell
per
ml
express
sfm
medium
invitrogen
life
technolog
supplement
fb
uml
penicillin
uml
streptomycin
mgl
lglutamin
without
addit
co
construct
hingehistagdaf
dna
fragment
contain
sequenc
human
hing
region
sequenc
encod
x
tag
ctermin
amino
acid
residu
daf
stop
codon
sequenc
sal
site
addit
bp
link
recurs
pcr
anoth
dna
fragment
contain
sequenc
bgl
ii
site
addit
bp
sequenc
encod
signal
peptid
scfv
residu
human
hing
region
sequenc
tag
amplifi
pcr
use
previous
gener
plncxtcrmscfv
templat
two
fragment
design
way
nucleotid
overlap
scfvhing
tagdaf
fragment
addit
xba
site
insert
sequenc
signal
peptid
scfv
xma
site
insert
sequenc
scfv
hing
region
facilit
clone
process
scfv
see
whole
fragment
encod
entir
scfv
hingehistag
daf
gener
overlap
pcr
amplifi
cdna
ligat
ta
vector
system
invitrogen
life
technolog
sequenc
analysi
cdna
contain
correct
scfv
hingehistag
daf
clone
bam
hi
sal
site
lentivir
transfer
vector
result
lentivir
transfer
construct
design
prrlscfv
hingehistagdaf
figur
construct
gene
encod
scfv
overlap
primer
recurs
pcr
synthes
accord
publish
sequenc
end
primer
recurs
pcr
design
way
xba
xma
site
introduc
end
scfv
gene
respect
gene
encod
scfv
deriv
vh
vl
fragment
human
monoclon
antibodi
gener
convalesc
plasma
avian
influenza
viru
infect
patient
laboratori
amplifi
gene
encod
scfv
ligat
ta
vector
system
sequenc
cdna
contain
correct
scfv
insert
xba
xma
site
prrlscfv
hingehistagdaf
result
lentivir
transfer
construct
design
prrlscfv
hingehistagdaf
respect
see
figur
addit
file
construct
secretori
form
scfv
gene
encod
sequenc
contain
signal
peptid
scfv
hing
histag
stop
codon
first
amplifi
pcr
use
prrlscfv
hingehistagdaf
templat
correct
sequenc
insert
bam
hi
sal
site
prrlscfv
hingehistagdaf
gener
lentivir
transfer
construct
prrlscfv
hingehistag
sequenc
encod
scfv
insert
xba
xma
site
prrlscfv
hingehistag
result
lentivir
transfer
construct
design
prrlscfv
hing
histag
respect
figur
addit
file
gener
gene
encod
solubl
human
protein
produc
drosophila
cell
gene
encod
extracellular
domain
human
protein
histag
cterminu
pcramplifi
use
total
rna
isol
cemss
cell
templat
ligat
ta
vector
describ
correct
gene
sequenc
insert
bgl
ii
bstb
site
induc
express
vector
invitrogen
result
plasmid
design
gene
encod
retrovir
envelop
pcramplifi
packag
cell
line
origin
develop
dusti
miller
laboratori
gene
encod
envelop
pcramplifi
provir
dna
see
correct
sequenc
clone
sal
bam
hi
site
cmvr
express
vector
result
plasmid
design
cmv
renv
cmvrenv
respect
gene
encod
human
pcr
amplifi
use
total
rna
isol
human
pbmc
templat
ligat
ta
vector
describ
correct
gene
sequenc
insert
bam
hi
sal
site
lentivir
transfer
vector
result
lentivir
transfer
construct
design
recombin
lentivir
vector
gener
describ
briefli
cell
seed
onto
dish
ml
complet
dmem
overnight
cultur
cell
cotransfect
transfer
construct
one
prrlscfvhingehistagdaf
prrlscfvhingehistag
well
packag
construct
encod
gag
pol
plasmid
encod
vsvg
envelop
plpvsvg
rev
protein
invitrogen
use
calcium
phosphat
precipit
method
sixteen
hour
later
cultur
supernat
remov
replac
fresh
complet
dmem
plu
mm
sodium
butyr
sigma
eight
hour
later
supernat
remov
replac
fresh
dmem
plu
fb
anoth
hour
cultur
supernat
harvest
concentr
ultracentrifug
describ
vector
pellet
resuspend
small
volum
dmem
store
aliquot
degre
freezer
vector
titer
determin
previous
describ
amount
gag
concentr
vector
stock
determin
elisa
see
gener
cell
cemss
cell
tu
recombin
lentivir
vector
express
human
ad
onto
tissu
cultur
plate
presenc
polybren
sigma
twenti
four
hour
later
cell
extens
wash
cultur
complet
dmem
express
measur
fac
analys
gener
solubl
drosophila
cell
solubl
gener
accord
manufactur
instruct
briefli
cell
seed
onto
well
plate
ml
express
sfm
medium
overnight
cultur
cell
cotransfect
pcoblast
invitrogen
life
technolog
use
calcium
phosphat
precipit
method
forti
eight
hour
later
blasticidin
ad
medium
select
stabli
cotransfect
cell
line
follow
limit
dilut
assay
select
stabl
cell
clone
produc
stabl
clone
induc
cdcl
day
solubl
supernat
harvest
purifi
ninta
column
invitrogen
accord
manufactur
instruct
amount
protein
quantifi
bca
assay
pierc
puriti
protein
determin
sdspage
follow
coomassi
blue
stain
transduc
cemss
cell
cemss
cell
tu
one
lentivir
vector
contain
prrlscfv
hingehistagdaf
prrlscfv
hingehistag
ad
onto
tissu
cultur
plate
presenc
polybren
sigma
twenti
four
hour
later
cell
extens
wash
cultur
complet
dmem
transduc
tzmbl
cell
tmzbl
cell
per
well
seed
onto
well
plate
overnight
cultur
tu
one
lentivir
vector
contain
prrlscfv
hingehistagdaf
prrlscfv
hingehistag
ad
onto
tissu
cultur
plate
presenc
polybren
twenti
four
hour
later
cell
extens
wash
cultur
complet
dmem
express
scfv
hingehistagdaf
construct
measur
fac
western
blot
analys
express
scfvhing
histag
measur
western
blot
analysi
see
usual
found
singl
round
transduct
cell
express
transgen
data
shown
transduc
cell
gener
cell
continu
cultur
complet
dmem
split
everi
day
period
express
transgen
measur
found
level
transgen
express
stabl
transduc
cell
line
data
shown
studi
cell
surfac
express
scfvhingehistag
daf
mockand
scfv
hingehistagdaftransduc
tzm
bl
cell
mockand
scfv
hingehistag
daftransduc
cell
incub
mous
antihistag
antibodi
sigma
min
ice
cell
wash
twice
fac
buffer
pb
contain
bsa
nan
stain
peconjug
goat
antimous
igg
antibodi
sigma
anoth
min
ice
cell
wash
twice
fac
buffer
fix
formaldehyd
ml
fac
buffer
fac
analysi
perform
facscan
becton
dickinson
mountain
view
ca
determin
whether
express
scfv
hingehistagdaf
truli
gpi
anchor
mockand
scfv
hingehistagdaftransduc
tmzbl
cell
first
incub
without
piplc
prozym
san
leandro
ca
usa
dmem
contain
fb
min
incub
cell
wash
twice
remov
remain
piplc
stain
mous
antihistag
antibodi
describ
western
blot
analysi
cell
tzmblgpiscfv
tzmblscfv
grown
dmem
plu
fb
plate
hour
cell
supernat
harvest
respect
cell
lyse
lysi
buffer
mm
trishcl
presenc
proteas
inhibitor
cocktail
calbiochem
protein
supernat
precipit
tca
dissolv
equal
volum
lysi
buffer
lyse
cell
pellet
sampl
detect
mous
antihi
tag
antibodi
sigma
mous
anti
human
betatubulin
antibodi
refer
control
gener
pseudotyp
vector
packag
cell
cotransfect
transfer
vector
dna
plasmid
encod
one
envelop
ada
jrfl
consensu
b
control
retrovir
envelop
use
calcium
phosphat
precipit
method
see
dna
plasmid
encod
envelop
ada
jrfl
obtain
arrrp
dna
plasmid
encod
consensu
b
gener
gift
dr
bh
hahn
univers
alabama
dna
plasmid
encod
obtain
dr
linqi
zhang
tsinghua
univers
envelop
deriv
tropic
clade
viru
envelop
ada
jrfl
deriv
tropic
clade
b
virus
envelop
deriv
tropic
clade
b
viru
envelop
consensu
b
artifici
envelop
origin
gener
dr
hahn
laboratori
envelop
deriv
tropic
clade
c
virus
envelop
deriv
tropic
clade
viru
envelop
deriv
tropic
clade
b
viru
envelop
deriv
tropic
clade
c
viru
zhang
et
al
unpublish
data
pseudotypecontain
supernat
harvest
store
aliquot
degre
freezer
amount
collect
supernat
measur
elisa
singlecycl
assay
measur
infect
pseudotyp
mock
scfvhingehistag
scfvhing
histagdaftransduc
tzmbl
cell
transduc
pseudotypecontain
supernat
equival
rel
luciferas
activ
overnight
cell
wash
twice
pb
cultur
complet
dmem
medium
day
cell
wash
pb
lyse
lysi
buffer
luciferas
activ
cell
suspens
measur
brightglo
luciferas
assay
accord
manufactur
instruct
promega
mock
scfvhingehistag
scfvhingehistagdaftransduc
tmzbl
cell
cell
per
well
seed
onto
plate
overnight
cultur
cell
infect
strain
jsjcd
tcid
final
volum
ml
overnight
cell
wash
three
time
hbss
resuspend
ml
complet
dmem
medium
incub
day
infect
determin
brightglo
luciferas
assay
see
test
effect
antihiv
potenc
secretori
gpianchor
scfv
parent
tzm
bl
cell
tzmblscfv
tzmblgpiscfv
cell
per
well
seed
onto
plate
incub
overnight
tcid
tcid
first
mix
without
predetermin
minut
virus
without
ad
onto
parent
tzmbl
cell
tzmblscfv
tzmblgpiscfv
cell
day
infect
determin
brightglo
luciferas
assay
see
long
term
cultur
infect
cell
cell
transduc
gpiscfv
secretori
scfv
infect
strain
tcid
final
volum
ml
overnight
cell
extens
wash
hbss
resuspend
ml
complet
dmem
cultur
week
everi
day
ml
cell
suspens
harvest
replac
fresh
medium
supernat
collect
supernat
measur
elisa
beckman
coulter
accord
manufactur
instruct
cellcel
fusion
experi
cell
per
well
without
tetracyclin
treatment
grown
plate
overnight
cemssgpiscfv
ad
onto
cell
cellcel
fusion
monitor
light
microscopi
variou
time
interv
fusion
process
reach
peak
hour
result
record
ccd
digit
camera
leica
dm
irb
peripher
blood
obtain
healthi
donor
gulf
coast
region
blood
center
houston
texa
peripher
blood
mononuclear
cell
pbmc
isol
use
ficol
densiti
gradient
centrifug
describ
isol
monocyt
microbead
minimac
system
use
accord
manufactur
instruct
miltenyi
biotech
auburn
ca
briefli
pbmc
resuspend
bind
buffer
pb
contain
bsa
mm
edta
mac
microbead
ad
mix
incub
minut
cellbead
mixtur
wash
bind
buffer
resuspend
ml
fresh
bind
buffer
cell
posit
select
use
msr
column
tip
isol
cell
wash
complet
rpmi
cultur
complet
rpmi
supplement
gmcsf
u
ml
uml
r
system
minneapoli
mn
day
gener
immatur
dc
describ
express
dcsign
cell
surfac
immatur
dc
measur
antidcsign
antibodi
stain
follow
fac
analysi
describ
dc
per
well
seed
triplic
well
ubottom
plate
incub
tcid
total
volum
co
hour
cell
wash
three
time
pb
remov
cellfre
viru
resuspend
ml
complet
rpmi
well
plate
without
ad
cemssgpiscfv
cell
cell
continu
cultur
day
everi
day
medium
remov
well
replac
fresh
complet
medium
supernat
measur
elisa
describ
parent
tzmblgpiscfv
cell
seed
cell
per
well
onto
labtek
chamber
slide
nalg
nunc
intern
rochest
ny
incub
co
day
cell
wash
twice
pb
fix
fixat
buffer
formaldehyd
pb
plu
bsa
min
cell
wash
twice
pb
block
blockag
buffer
goat
serum
pb
plu
bsa
hour
cell
stain
alexa
conjug
ctxb
invitrogen
life
technolog
min
wash
time
pb
cell
stain
mous
antihistag
antibodi
sigma
min
stain
alexa
goat
antimous
igg
antibodi
invitrogen
cell
wash
time
pb
cell
stain
dapi
permeabil
buffer
blockag
buffer
plu
saponin
min
slide
mount
analyz
confoc
fluoresc
microscop
zeiss
model
lsm
